Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance
Go back to Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 108.73 +0.33 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.40 | 52 Week High | $39.41 | |||
| Open | $109.24 | 52 Week Low | $25.98 | |||
| Day High | $110.06 | P/E | 153.14 | |||
| Day Low | $108.05 | EPS | $0.71 | |||
| Volume | 327,027 | |||||
